A lateral flow immunoassay produces a visible answer within minutes and requires no bench instruments with a drop of blood, urine, or saliva. Distribution and procurement teams generally see only the end result (the cassette), not the physical sample in between.
The journey from sample landing on a strip to the formation of a colored line gives some perspective on quality assessment and helps R&D teams communicate with their manufacturing partners. Every lateral flow immunoassay produced on our production line is based on four elements that operate sequentially.
This is a step-by-step look that has more significance than curiosity. When a distributor understands what can go wrong in a lateral flow immunoassay, they will know what questions to pose the supplier during their due diligence process, and an R&D scientist deciding on an OEM partner can ask what materials and tolerances actually affect the performance of an immunoassay.
This guide takes you through each step of that process, and then shows you the manufacturing controls Neo Nostics uses to ensure that your results are consistent from batch to batch.
The Four-Component Pathway
All lateral flow immunoassays share the same basic structure: a sample pad, a conjugate pad, a nitrocellulose (NC) membrane, and an absorbent pad. Each piece is located downstream from the previous piece, and the sample moves by capillary action through these. No pump, battery, or reader drives the flow. Gravity and surface tension do the work instead, which is why this format anchors point-of-care testing (POCT) worldwide.
Manufacturers laminate these four components on a single card, divide it into separate test strips, and place each strip in a plastic cassette. That assembly step seems straightforward, but it will factor in whether all the strips in a production run will act in the same way. Capillary flow speed will vary from strip to strip if the pad overlap is inconsistent or if the lamination pressure varies, even if the raw materials are in specification themselves.
Step 1: Sample Application and Capillary Migration
Capillary migration through the strip
This begins with the user applying the sample directly onto the sample pad. This pad not only absorbs the sample liquid, but it also filters out particulates and red blood cells and buffers the sample pH to ensure predictable chemistry downstream.
Capillary forces draw the liquid laterally as the pad fills, towards the conjugate pad. Manufacturers choose sample pad material carefully, because irregular wicking at this stage distorts every result that follows.
Step 2: Conjugate Release and the Recognition Reaction
The migrating sample then reaches the conjugate pad, where dried colloidal gold-antibody conjugates rehydrate back into solution. The recognition reaction takes place here when the target analyte is present; it will attach to the gold nanoparticles coated with antibody to form a complex, which will continue to move along with the flow.
This is where the colloidal gold method earns its reputation: gold nanoparticles carry an intense, naturally visible color that needs no external label or excitation source to read later. The dried chemicals in the conjugate pad must be fully released, and in a controlled manner; otherwise, the result downstream is unpredictable.
During manufacturing, stabilising agents treat the pad material specifically to control the release rate and protect the antibody-gold conjugates from degrading in storage. A pad that releases reagent too slowly starves the reaction before the sample reaches the membrane; one that releases too quickly floods the strip with background staining that can mask a faint positive.
Step 3: NC Membrane and T/C Line Formation
Formation of the Test (T) and Control (C) lines
The sample then crosses onto the NC membrane, the most technically demanding component in any lateral flow immunoassay. This membrane has two thin lines of antibodies: a Test (T) line and a Control (C) line. The antigen-antibody-gold complex moves to the T line where immobilized capture antibodies bind to the complex, causing a coloured band to form as the gold particles accumulate.
A separate antibody at the C line captures any unbound conjugate regardless of the test result, confirming the assay ran correctly. If the C line is not present, the test is not valid; if the T line is present, the test is positive.
Step 4: The Absorbent Pad
Lastly, the sample comes into contact with the absorbent pad at the opposite end of the strip. This pad draws the liquid that’s left behind across the membrane at a steady pace, preventing it from flowing back in the opposite direction, and, of course, blurring the lines, which would make it difficult to read. Proven absorbent pad technology ensures uniform flow speed from strip to strip within a batch to help ensure reproducible results.
Manufacturing Detail: What Actually Determines Lateral Flow Immunoassay Quality
Manufacturing controls for consistent assay quality
It’s one thing to explain the pathway and another to control it at scale. A handful of manufacturing controls separate a reliable lateral flow immunoassay from an inconsistent one, and most field complaints trace back to a lapse in one of them.
At the top of that list is particle size control. During the synthesis of colloidal gold particles, Neo Nostics precisely controls the diameter of the particles, as this will directly impact the sensitivity of the assay and the intensity of color. If the particle size is not consistent, the T line will not scatter the light uniformly, and fainter positives will be more difficult to read.
Batch-to-batch consistency depends on holding particle synthesis and reagent dispensing within a tight statistical range. We aim to provide an intra-batch precision (CV) of ≤15% and an inter-batch precision (CV) of ≤15%, meaning that a strip produced this week will be the same as a strip produced the following month.
The type of NC membrane used is as important as the chemicals applied to it. We test each membrane candidate for the capillary flow rate (wicking time), protein binding capacity, and pore structure, since a membrane which wicks too fast tends to produce faint lines; and a membrane which wicks too slowly tends to lengthen test time and increase background staining. It is this balance that creates a crisp, legible line in a pure background.
All of this manufacturing discipline leads to a shelf life of 24 months at room temperature, a critical factor for distributors shipping into markets without a well-developed cold-chain infrastructure. Packaging discipline is as important as formulation to achieve that shelf life: Neo Nostics seals finished cassettes in humidity-resistant pouches, so a well-formulated conjugate can lose activity if the humidity gets to the strip during storage or transit.
Why Instrument-Free POCT Matters
The benefits of this format are self-evident. A lateral flow immunoassay needs no special equipment to interpret, so a clinic, pharmacy, or household can run a single test without one.
This format is inexpensive to produce, is suitable for a large variety of specimen types, and, with the shelf-life numbers listed above, is well adapted for travel to field clinics and export. This simplicity and stability are typically the clinching factor for distributors who are considering rapid tests in comparison to laboratory-based tests.
These pluses are multiplied by speed. Most lateral flow immunoassays will give you a readable result in 10-15 minutes versus hours or days when sent to a centralized laboratory. That turnaround allows a clinician to make a treatment decision in a single visit, and a household to receive an answer without having to leave home, without the expense of the equipment needed in a lab-based platform.
What We’re Working On Now
We don’t want to predict where the industry is going; we can just look at two initiatives that are already taking place on our production floor.
In the first instance, our R&D team is creating multiplex test cards that will allow for the identification of two to five biomarkers at once, on a single test card, thus decreasing the number of individual tests a clinician or household has to perform.
Second, we are rolling out automated dispensing equipment in our production process specifically to further reduce variability from batch to batch; we will be providing specific performance data as we roll this out.
Built for Distributors at Scale
None of this technical detail matters to a buyer unless the manufacturer can deliver at volume. With a minimum order quantity of only 1,000 tests, Neo Nostics’ monthly production capacity of 1.5 million tests allows established distributors as well as smaller buyers that are testing a new market to buy what they need.
Standard production lead time runs around 5 working days, depending on order volume, and Neo Nostics already ships to customers across Europe, Southeast Asia, and Africa. Neo Nostics manufactures every lateral flow immunoassay under CE and ISO 13485 certification, giving procurement teams a documented quality framework for their due diligence.
Talk to Our Team
If your organization is evaluating a new lateral flow immunoassay supplier, don’t take the manufacturing claims at face value; see the product and the process for yourself. Request Samples or schedule a factory audit with our team to review particle synthesis, membrane sourcing, and QC data firsthand.
